Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 87604011 | FILING DATE | 09/11/2017 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | REIHNER, DAVID C | L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
RUN DATE | 06/21/2018 | ||
PUB DATE | N/A | ||
STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
STATUS DATE | 06/20/2018 | ||
LITERAL MARK ELEMENT | NITYR | ||
|
|||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
|
|
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
44D | YES | 44D | NO | 44D | NO |
44E | YES | 44E | YES | 44E | NO |
66A | NO | 66A | NO |
|
|
NO BASIS | NO | NO BASIS | NO |
|
|
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | NITYR |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Cycle Pharmaceuticals Ltd. |
ADDRESS | Bailey Grundy Barrett Building Little St Mary's Lane Cambridge, CB21RR |
ENTITY | 03-CORPORATION |
CITIZENSHIP | United Kingdom |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical agents for the treatment of disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
INTERNATIONAL CLASS | 035 |
DESCRIPTION TEXT | Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
INTERNATIONAL CLASS | 044 |
DESCRIPTION TEXT | Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medical, pharmacological and pharmaceutical products providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 035 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON United Kingdom |
APPLICATION NO. | 00003249423 |
APPLICATION FILING DATE | 08/10/2017 |
FOREIGN REG NO. | 00003249423 |
FOREIGN REG DATE | 11/03/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 08/10/2017 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | 00003219996 |
APPLICATION FILING DATE | 03/21/2017 |
FOREIGN REG NO. | 00003219996 |
FOREIGN REG DATE | 06/09/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 03/21/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | UK0000321999 |
APPLICATION FILING DATE | 03/21/2017 |
FOREIGN REG NO. | UK0000321999 |
FOREIGN REG DATE | 06/09/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 03/21/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | UK0000324942 |
APPLICATION FILING DATE | 08/10/2017 |
FOREIGN REG NO. | UK0000324942 |
FOREIGN REG DATE | 11/03/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 08/10/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | UK0000324942 |
APPLICATION FILING DATE | 08/10/2017 |
FOREIGN REG NO. | UK0000324942 |
FOREIGN REG DATE | 11/03/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 08/10/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | UK0000324942 |
APPLICATION FILING DATE | 08/10/2017 |
FOREIGN REG NO. | UK0000324942 |
FOREIGN REG DATE | 11/03/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 08/10/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PRIORITY CLAIMED | N/A |
APPLICATION NO. | UK0000324942 |
APPLICATION FILING DATE | 08/10/2017 |
FOREIGN REG NO. | UK0000324942 |
FOREIGN REG DATE | 11/03/2017 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 08/10/2027 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
06/20/2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 017 |
06/20/2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 016 |
06/11/2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 015 |
05/01/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 014 |
05/01/2018 | GNRT | O | NON-FINAL ACTION E-MAILED | 013 |
05/01/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 012 |
04/11/2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 011 |
04/11/2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 010 |
04/05/2018 | ALIE | A | ASSIGNED TO LIE | 009 |
03/22/2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
12/19/2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 007 |
12/14/2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
12/14/2017 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
12/14/2017 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
12/14/2017 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
09/15/2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
09/14/2017 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Kristin Grant |
CORRESPONDENCE ADDRESS | KRISTIN GRANT GRANT ATTORNEYS AT LAW PLLC 211 East 43rd Street, 7th Floor NEW YORK, NY 10017 |
DOMESTIC REPRESENTATIVE | NONE |